celecoxib has been researched along with Hearing Loss in 1 studies
Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose celecoxib (2 g/kg), a selective COX-2 inhibitor, did not cause hearing loss or tinnitus in Sprague Dawley rats within 48 hours of administration." | 3.81 | Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats. ( Feng, Y; Li, B; Su, K; Xia, L; Yang, G; Yin, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B | 1 |
| Su, K | 1 |
| Yang, G | 1 |
| Feng, Y | 1 |
| Xia, L | 1 |
| Yin, S | 1 |
1 other study available for celecoxib and Hearing Loss
| Article | Year |
|---|---|
Assessment of the potential ototoxicity of high-dose celecoxib, a selective cyclooxygenase-2 inhibitor, in rats.
Topics: Animals; Auditory Threshold; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Re | 2015 |